Rejected at 5:31 p.m. Mar, 25, 2024 ] by Ahmed7
Author: lawsonspence
Related Note: 1509216688328
Rationale for change

helps me know what the blood smear would look like
Source: AMBOSS - https://next.amboss.com/us/search?q=megaloblastic+anemia&v=overview

Rejection reason

copyright

Extra Extra
Text
Which type of anemia can result from cytarabine use?

{{c1::Megaloblastic (macrocytic) anemia}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy

Watch Cytotoxic Nucleoside Analogs
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Physeo

Bootcamp
Watch associated Bootcamp video - Cellular Injury and Neoplasia: Cell Cycle Dependent Drug Targets

Watch associated Bootcamp video - Principles of Oncology and Therapeutics: Cell Cycle Dependent Drug Targets

Watch associated Bootcamp video - Acute Myeloid Leukemia
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::09_Cladribine_Cytarabine #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::06_Cytarabine #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::09_Leukemias_and_Lymphomas::01_Acute_Myeloid_Leukemia #AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::05_Pharm::12_Antimetabolites #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::01_Antimetabolites::03_Cytotoxic_Nucleoside_Analogs #AK_Step1_v12::#FirstAid::05_Pharmacology::03_Toxicities_&_Side_Effects::05_Drug_reactions_-_hematologic #AK_Step1_v12::#B&B::03_Biochem::01_Molecular::03_Pyrimidine_Metabolism #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::10_Cell_Cycle_Dependent_Drug_Targets #AK_Step1_v12::#B&B::11_Hematology::04_Cancer_Drugs::01_Antimetabolites !AK_UpdateTags::Step1decks::Lolnotacop::Drugs #AK_Step1_v12::#B&B::03_Biochem::01_Molecular::03_Pyrimidine_Metabolism::Lolnotacop #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::10_Cell_Cycle_Dependent_Drug_Targets #AK_Step1_v12::#OME_banner #AK_Step2_v12::#B&B::07_Hematology_&_Oncology::01_Red_Cells::04_Macrocytic_Anemia #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::05_Pharm::12_Antimetabolites::Nucleoside_Analogs::Cytarabine